Patents by Inventor Larry Dillaha

Larry Dillaha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240207285
    Abstract: Provided herein are pharmaceutical compositions comprising midazolam and ketamine, and methods of inducing sedation (e.g., procedural sedation) in a subject using administration of such compositions, the compositions optionally including a pharmaceutically active compound of a third class. Compositions may be in sublingual or buccal form, or incorporated into vehicles for extended release. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Application
    Filed: December 20, 2023
    Publication date: June 27, 2024
    Inventor: Larry Dillaha
  • Publication number: 20170112858
    Abstract: The present invention is directed to methods of inhibiting platelet aggregation, reducing serum thromboxane B2 levels, reducing systemic or cardiovascular inflammation, treating or preventing cancer and treating or preventing cardiovascular disease by oral administration of compositions containing extended release acetylsalicylic acid (ASA) or a combination of extended release ASA and immediate release ASA.
    Type: Application
    Filed: April 18, 2016
    Publication date: April 27, 2017
    Inventors: Larry Dillaha, Jeff Patrick
  • Publication number: 20170112857
    Abstract: The present invention is directed to methods of inhibiting platelet aggregation, reducing serum thromboxane B2 levels, reducing systemic or cardiovascular inflammation, treating or preventing cancer and treating or preventing cardiovascular disease by oral administration of compositions containing extended release acetylsalicylic acid (ASA) or a combination of extended release ASA and immediate release ASA.
    Type: Application
    Filed: April 18, 2016
    Publication date: April 27, 2017
    Inventors: Larry Dillaha, Jeff Patrick
  • Publication number: 20090093547
    Abstract: Compositions and methods for the treatment of premature ejaculation have been developed. It has been discovered that premature ejaculation can be treated by administering a local anesthetic to the glans penis. The local anesthetic may be formulated as an emulsion, lotion, paste, gel, cream, ointment, shea butter, suspension, solution, balm, salve, foam, or in the form of a pump spray to achieve local anesthesia of the dorsal neurons of the penis.
    Type: Application
    Filed: October 9, 2007
    Publication date: April 9, 2009
    Inventors: James M. Corbitt, Brian Adams, Larry Dillaha
  • Publication number: 20080317832
    Abstract: In one aspect, the invention includes a method for treating sialorrhea, comprising the steps of identifying a patient afflicted with sialorrhea and administering a therapeutically effective amount of glycopyrrolate to the patient using a transdermal route of administration. In another aspect, the invention is a transdermal drug delivery system for treating a patient exhibiting sialorrhea, including a transdermal patch, a therapeutically effective amount of glycopyrrolate contained in the transdermal patch to alleviate sialorrhea, and a pharmaceutically acceptable carrier. The transdermal patch can be a single layer drug-in-adhesive patch, a multi-layer drug-in-adhesive patch, a matrix patch, or a reservoir patch.
    Type: Application
    Filed: June 23, 2008
    Publication date: December 25, 2008
    Applicant: Sciele Pharma, Inc.
    Inventor: LARRY DILLAHA
  • Publication number: 20080260823
    Abstract: The invention provides an orally disintegrating tablet comprising a therapeutically effective amount of glycopyrrolate for treating sialorrhea, as well as a kit comprising the orally disintegrating tablet, prescribing information, and a container. The invention also provides a method of treating sialorrhea in a patient comprising administering the orally disintegrating tablet comprising a therapeutically effective amount of glycopyrrolate to the patient.
    Type: Application
    Filed: April 20, 2007
    Publication date: October 23, 2008
    Applicant: Sciele Pharma, Inc.
    Inventor: Larry Dillaha
  • Publication number: 20080153831
    Abstract: Compositions and methods for the prevention and treatment of osteoporosis are provided herein. The compositions contain one or more isoflavones, such as genistein and derivatives thereof, in combination with one or more folates, such as a reduced folate and/or folic acid; and/or one or more polyunsaturated fatty acids (PUFAs), such as an omega-3 and/or omega-6 fatty acid. The isoflavones, folates and/or essential fatty acid may be administered together or in separate dosage units. The compositions may optionally contain other vitamins, minerals, and ingredients, such as, emollient laxatives. The compositions are useful in the treatment of all forms of osteoporosis, including primary osteoporosis and secondary osteoporosis, and/or inflammatory joint diseases, especially in patients having a folic acid metabolism deficiency. The compositions are particularly useful in the treatment of inflammatory joint diseases, with complications that include bone loss, fracture, and osteoporosis.
    Type: Application
    Filed: October 19, 2007
    Publication date: June 26, 2008
    Inventors: Larry Dillaha, Brian Adams